Abstract
SA66 Patient Demographic and Clinical Characteristics Associated With the Use of the Newly Approved Disease-Modifying Medications for Sickle Cell Disease
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
